TokenPost·
Merck, Eli Lilly Enter Earnings Reports With Declines Expected
Analysts project Merck’s earnings per share at $2.09, down 19% from a year earlier.
More news
- TokenPostSMT Scharf Lowers 2026 Revenue Forecast to €75 Million to €85 Million
- TokenPostOceanFirst Declares $0.20 Quarterly Dividend Payable Nov. 20
- TokenPostResearchers Demonstrate Telegram Sticker Flaw With Zero-Click iOS Code Risk
- TokenPostJim Cramer Sees Long-Term Potential in Boeing, GE Vernova Stocks
- Crypto BriefingPerplexity taps OpenAI’s gpt-live-1 to power its voice mode
- Crypto BriefingMicrosoft Foundry passes 120,000 customers as revenue more than triples